| Name | Title | Contact Details |
|---|
Mantra Health is a digital mental health clinic on a mission to improve young peoples` mental healthcare access through clinical services, software, and design. Since our founding in 2018, we`ve built a comprehensive treatment service for young adults with various mental health conditions. We`ve raised over $27 million to work with students at universities and colleges across the country such as MIT, Cornell, and the University of Minnesota. Our students see clinically significant differences in their mental health during treatment with us. We`re particularly proud that nearly two-thirds of students with access to Mantra report that Mantra`s program helped them stay in school.
Healthcare Purchasing Alliance (HPA) is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Quilleer and Blake Advertising is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Triad Healthcare Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Triad Healthcare Inc. is based in Plainville, CT. You can find more information on Triad Healthcare Inc. at www.triadhealthcareinc.com
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.